Edition:
India

BrightPath Biotherapeutics Co Ltd (4594.T)

4594.T on Tokyo Stock Exchange

191JPY
18 Dec 2018
Change (% chg)

¥-9 (-4.50%)
Prev Close
¥200
Open
¥194
Day's High
¥195
Day's Low
¥189
Volume
501,800
Avg. Vol
484,462
52-wk High
¥968
52-wk Low
¥189

Summary

Name Age Since Current Position

Kenichi Nagai

45 2011 President, Chief Executive Officer, Representative Director

Yutaka Waki

57 2014 Chief Operating Officer, Director of Research Development, Director

Akira Yamada

58 2004 Director

Hirotaka Takeuchi

71 2015 Independent Director

Biographies

Name Description

Kenichi Nagai

Mr. Kenichi Nagai has been serving as President, Chief Executive Officer and Representative Director in GreenPeptide Co., Ltd. since March 2011. His previous titles include Chief Financial Officer and Director of Administration in the Company. He used to work for other three companies, including Merrill Lynch Japan Securities Co., Ltd. and Perseus Proteomics Inc.

Yutaka Waki

Mr. Yutaka Waki has been serving as Chief Operating Officer, Director of Research Development and Director in GreenPeptide Co., Ltd. since September 2014. He is also serving as Representative Director in PointPath.Biz, K. K. He used to work for Kyowa Hakko Kogyo Co., Ltd., Kyowa Pharmaceutical, Inc. and Shogoo Pharmaceuticals, K.K.

Akira Yamada

Mr. Akira Yamada has been serving as Director in GreenPeptide Co., Ltd. since January 2004. He is also a professor in Research Center for Innovative Cancer Therapy, Kurume University.

Hirotaka Takeuchi

Mr. Hirotaka Takeuchi has been serving as Independent Director in GreenPeptide Co., Ltd. since June 2015. He is also serving as Independent Director in INTEGRAL CORPORATION. He is also professor of Harvard University and . He used to work for Hitotsubashi University. He used to work for McCann Erickson Japan Inc.

Basic Compensation

Name Fiscal Year Total

Kenichi Nagai

--

Yutaka Waki

--

Akira Yamada

--

Hirotaka Takeuchi

--
As Of 

Options Compensation